Pharmafile Logo

Top 100 Creative Companies

- PMLiVE

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

Another BACE candidate is abandoned, leaving just one remaining in the pipeline

- PMLiVE

European pharma pips North America in remote physician engagement, according to Indegene-TEVA survey

European pharma companies have outperformed their American peers in applying remote physician engagement to their multi-channel marketing mix, according to the 2018 Indegene-TEVA survey. Among popular users, 35% of the...

- PMLiVE

Cancer Research UK to test Asterias’ lung cancer vaccine

The vaccine could treat NSCLC patients who are at risk of relapse

- PMLiVE

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

- PMLiVE

Exelixis appoints Andrew Peters to newly created position

He joins the biotech as its vice president, strategy

- PMLiVE

AbbVie, Roche get FDA OK for broader use of Venclexta

The drug is tipped to become a $2.5bn product by 2024

Patient outcomes in practice: delivering value that transforms lives

In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. In response to the increasing...

Lucid Group Communications Limited

Reaching the new influencers

With payers looking increasingly to real-world data, and to differentiation beyond this data through outcomes commitment and the provision of beyond the pill services, there’s never been a better time...

EU flag

UK pharma cheers EU science announcement

UK won't be excluded from Horizon research collaboration

Introducing eConnext™: The Next Generation of Online Conference Engagement

TORONTO, CANADA, June 8, 2018— Six Degrees Medical (SDM) announces the launch of eConnext™. eConnext™ combines SDM’s medical writing and pharmaceutical industry content development experience with state-of-the-art virtual meeting platforms...

Six Degrees Medical Consulting

- PMLiVE

Roche’s MabThera ends drug drought for serious skin disease

As biosimilars seize market share, Roche finds ways to extend blockbuster's revenues

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links